Comments
Loading...

Acutus Medical

AFIBOTCPK
Logo brought to you by Benzinga Data
$0.0570
0.000.00%
At close: -
$0.1200
0.06110.53%
After Hours: Nov 5, 9:29 AM EDT

Acutus Medical (OTC:AFIB) Stock, Earnings Estimates, EPS, And Revenue

Acutus Medical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date
Nov 14
EPS
$-0.030
Quarterly Revenue
$5.27M
Annual Revenue
(as of Sep 30)
$15.38M

Analyze the earnings history of Acutus Medical using advanced sorting and filters.

Data brought to you by Benzinga APIs

Acutus Medical (AFIB) Earnings Per Share

Quarterly Earnings Surprise Amount

Fiscal QuarterDate ReportedActual EPSEstimated EPSSurprise %
Q32023-11-08$-0.52$-0.6114.8 %
Q22023-08-07$-0.60$-0.611.64 %
Q12023-05-11$-0.59$-0.6914.5 %
Q42023-03-16$-0.48$-0.7132.4 %

Acutus Medical (AFIB) Revenue

Quarterly Revenue Surprise Amount

Fiscal QuarterDate ReportedActual RevenueEstimated RevenueSurprise %
Q32023-11-08$5.24M$4.83M8.45 %
Q22023-08-07$5.29M$4.60M15.0 %
Q12023-05-11$4.17M$3.85M8.31 %
Q42023-03-16$4.96M$4.32M14.9 %

FAQ

Q

When is Acutus Medical (OTCPK:AFIB) reporting earnings?

A

Acutus Medical (AFIB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3.

Q

What were the latest earnings per share (EPS) for Acutus Medical (OTCPK:AFIB)?

A

Acutus Medical (AFIB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual EPS was $-0.03, which missed the estimate of $0.00.

Q

What were Acutus Medical’s (OTCPK:AFIB) revenues?

A

Acutus Medical (AFIB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 14, 2024 for Q3 and the Actual Revenue was $5.3M, which beat the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.